Biotechnology Industry
Following issues related to the budget and appropriations process
FY14 appropriations for FDA as well as the potential outcomes for negotiations on altering sequestration targets via legislation. S.959, "Pharmaceutical Compounding Quality and Accounting Act"
H.R. 1416, "Cancer Patient Protection Act of 2013"
S.957, "Drug Supply Chain Security"
H.R. 1919, "Safeguarding America's Pharmaceuticals Act" General tax issues and tax extenders (R&D tax credit) and tax treatment of foreign-owned U.S. corporations.
BUD - Budget/Appropriations HCR - Health Issues TAX - Taxation/Internal Revenue Code
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
MISSY EDWARDS STRATEGIES, LLC
220 E Street, NE, Washington, DC, 20002, US
MELISSA M EDWARDS (Legislative Assistant, US Senator Thad Cochran) MELISSA M EDWARDS (Legislative Assistant, US Senator Thad Cochran) MELISSA M EDWARDS (Legislative Assistant, US Senator Thad Cochran)
Legislative Assistant, US Senator Thad Cochran Legislative Assistant, US Senator Thad Cochran Legislative Assistant, US Senator Thad Cochran